Author:
Anitha Kuttiappan,Chenchula Santenna,Ravula Parameshwar,Radhika Chikatipalli,Bhatt Shvetank
Publisher
Springer Nature Singapore
Reference58 articles.
1. Abele R, Tampe R (2006) Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett 580:1156–1163. https://doi.org/10.1016/j.febslet.2005.11.048
2. American Association for Cancer Research (2021) TROP2 ADC intrigues in NSCLC. Cancer Discov 11(5):OF5. https://doi.org/10.1158/2159-8290.CD-NB2021-0314
3. Anagnostou V, Cottrell TR, Forde PM, Chaft JE, Smith KN, Hellmann MD et al (2018) Neoadjuvant PD-1 inhibition in lung cancer with curative intent. N Engl J Med 378(21):1976–1986. https://doi.org/10.1056/NEJMoa1716078
4. Baskaran R, Lee J, Yang SG (2018) Clinical development of photodynamic agents and therapeutic applications. Biomater Res 22:25
5. Baum RP, Kulkarni HR, Muller D, Satz S, Danthi N, Kim YS, Brechbiel MW (2015) First-in-human study demonstrating tumor-angiogenesis by PET/CT imaging with 68Ga-NODAGA-THERANOST, a high-affinity peptidomimetic for αvβ3 integrin receptor targeting. Cancer Biother Radiopharm 30(4):152–159